Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
2
×
life sciences
national
national blog main
national top stories
san francisco blog main
san francisco top stories
blueprint medicines
boulder/denver blog main
boulder/denver top stories
clinical trials
companion diagnostic
crispr
crispr therapeutics
crispr-cas9
detroit blog main
detroit top stories
dna sequencing
drugs
editas
editas medicine
entrectinib
express scripts
fda
foundation medicine
indiana blog main
indiana top stories
intellia therapeutics
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
merck
new england journal of medicine
new york blog main
new york top stories
ntrk
What
cancer
genetic
2
×
medicine
2
×
new
approved
cas
cells
crispr
deeper
defect
dna
drive
drug
edited
editing
fda
fears
fingerprint
flag
gene
going
guardian
human
known
lab
malfunction
matter
nature
nd
nicknamed
occurs
oks
papers
potential
published
raising
red
researchers
risks
second
Language
Current search:
xconomy.com
×
medicine
×
genetic
×
cancer
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells